'Telelactation' Support Boosts Breastfeeding Rates

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on March 4, 2025.

By Lori Solomon HealthDay Reporter

TUESDAY, March 4, 2025 -- Mothers who are given access to virtual breastfeeding support report more breastfeeding than peers who did not receive such help, according to a study published online Feb. 27 in JAMA Network Open.

Lori Uscher-Pines, Ph.D., from RAND Corporation in Arlington, Virginia, and colleagues assessed the impact of video telelactation services on breastfeeding duration and exclusivity. The analysis included 1,911 pregnant individuals randomly assigned to receive access to a smartphone app with on-demand access to lactation consultants 24 hours a day via video visits or to a control arm, which received an infant care e-book.

The researchers found that 48.8 percent assigned to the treatment group used telelactation services. The proportion who reported any breastfeeding at 24 weeks was 70.6 percent in the treatment group and 66.8 percent in the control group, while the proportion with exclusive breastfeeding at 24 weeks was 46.9 percent in the treatment group and 44.1 percent in the control arm. Among Black participants, the proportion reporting any breastfeeding at 24 weeks was 65.1 percent in the treatment group and 57.4 percent in the control group, while the proportion reporting breastfeeding exclusively at 24 weeks was 42.7 and 33.9 percent, respectively.

"The results suggest that telelactation services could be a component of a comprehensive strategy to reduce racial disparities in breastfeeding rates," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-03-05 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords